Liesner R - Search Results

1

Normal lytic granule secretion by cytotoxic T lymphocytes deficient in BLOC-1, -2 and -3 and myosins Va, VIIa and XV.

Bossi G, Booth S, Clark R, Davis EG, Liesner R, Richards K, Starcevic M, Stinchcombe J, Trambas C, Dell'Angelica EC, Griffiths GM. Bossi G, et al. Among authors: liesner r. Traffic. 2005 Mar;6(3):243-51. doi: 10.1111/j.1600-0854.2005.00264.x. Traffic. 2005. PMID: 15702992 Free article.

2

The use of recombinant factor VIIa in children with inherited platelet function disorders.

Almeida AM, Khair K, Hann I, Liesner R. Almeida AM, et al. Among authors: liesner r. Br J Haematol. 2003 May;121(3):477-81. doi: 10.1046/j.1365-2141.2003.04286.x. Br J Haematol. 2003. PMID: 12716372 Free article.

3

The ophthalmic presentation of Hermansky-Pudlak syndrome 6.

Hull S, Arno G, Holder GE, Plagnol V, Gomez K, Liesner R, Webster AR, Moore AT. Hull S, et al. Among authors: liesner r. Br J Ophthalmol. 2016 Nov;100(11):1521-1524. doi: 10.1136/bjophthalmol-2015-308067. Epub 2016 Jan 28. Br J Ophthalmol. 2016. PMID: 26823395

4

Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.

O'Connell N, Mc Mahon C, Smith J, Khair K, Hann I, Liesner R, Smith OP. O'Connell N, et al. Among authors: liesner r. Br J Haematol. 2002 Mar;116(3):632-5. doi: 10.1046/j.0007-1048.2001.03324.x. Br J Haematol. 2002. PMID: 11849223 Free article.

5

Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.

Mathias M, Khair K, Hann I, Liesner R. Mathias M, et al. Among authors: liesner r. Br J Haematol. 2004 May;125(3):366-8. doi: 10.1111/j.1365-2141.2004.04916.x. Br J Haematol. 2004. PMID: 15086418 Free article.

6

Bruising and bleeding in infants and children--a practical approach.

Khair K, Liesner R. Khair K, et al. Among authors: liesner r. Br J Haematol. 2006 May;133(3):221-31. doi: 10.1111/j.1365-2141.2006.06016.x. Br J Haematol. 2006. PMID: 16643424 Free article. Review.

7

The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura.

Scully M, Gattens M, Khair K, Liesner R. Scully M, et al. Among authors: liesner r. Br J Haematol. 2006 Oct;135(1):101-4. doi: 10.1111/j.1365-2141.2006.06264.x. Epub 2006 Aug 22. Br J Haematol. 2006. PMID: 16925793 Free article.

8

Use of central venous catheters in children with severe congenital coagulopathy.

Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Liesner RJ, et al. Br J Haematol. 1995 Sep;91(1):203-7. doi: 10.1111/j.1365-2141.1995.tb05270.x. Br J Haematol. 1995. PMID: 7577634

9

The impact of prophyactic treatment on children with severe haemophilia.

Liesner RJ, Khair K, Hann IM. Liesner RJ, et al. Br J Haematol. 1996 Mar;92(4):973-8. doi: 10.1046/j.1365-2141.1996.420960.x. Br J Haematol. 1996. PMID: 8616096

10

Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy.

Ancliff PJ, Gale RE, Liesner R, Hann I, Linch DC. Ancliff PJ, et al. Among authors: liesner r. Br J Haematol. 2003 Feb;120(4):685-90. doi: 10.1046/j.1365-2141.2003.04160.x. Br J Haematol. 2003. PMID: 12588357 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters